New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 2, 2013
13:09 EDTACN, PLCE, HUM, TIVO, BIIB, GMEOptions with decreasing implied volatility: TIVO PLCE GME HUM ACN BIIB
News For TIVO;PLCE;GME;HUM;ACN;BIIB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 21, 2015
07:31 EDTBIIBBiogen says data presented from ATTAIN study demonstrate efficacy of Plegridy
Subscribe for More Information
April 20, 2015
07:32 EDTBIIBBiogen says new data supports Tecfidera as long-term treatment for MS patients
Subscribe for More Information
07:31 EDTTIVOTiVo management to meet with B. Riley
Subscribe for More Information
07:18 EDTBIIBAmerican Academy of Neurology to hold annual meeting
Subscribe for More Information
April 17, 2015
07:15 EDTGMEMarch NPD video game software sales declined 3%, says Piper Jaffray
Piper Jaffray notes March NPD video game software sales declined 3% year-over-year, with major titles for the month including Electronic Arts' (EA) Battlefield Hardline, Bloodborne from Sony (SNE) and Take-Two's (TTWO) Grand Theft Auto V. Piper notes the monthly decline is the first in 2015, leaving the segment up 2% through the first three months combined. It keeps Overweight ratings on Activision Blizzard (ATVI), Electronic Arts, GameStop (GME) and Take-Two.
April 16, 2015
07:21 EDTGMEGameStop estimates raised on stronger industry software sales at SunTrust
SunTrust says that video game software sales have finally turned positive, and the firm expects industry software sales to increase 3%-5% this year, given the momentum of the new hardware cycle and a better title lineup versus last year. SunTrust keeps a Buy rating on GameStop.
07:13 EDTACNAccenture awarded $966M contract to support federal student aid programs
Subscribe for More Information
05:10 EDTACNAccenture awarded contract by Tokyo Metropolitan government
Subscribe for More Information
April 15, 2015
07:14 EDTBIIBBiogen volatility flat into new drug data
Biogen overall option implied volatility of 35 compares to its 26-week average of 34 according to Track Data, suggesting non-directional into results as shares rally in the preopen on Phase 2 RENEW study of anti-LINGO-1 in acute optic neuritis clinical data.
April 14, 2015
18:30 EDTBIIBOn The Fly: After Hours Movers
Subscribe for More Information
16:12 EDTBIIBBiogen presents new Anti-LINGO-1 Phase 2 AON data
Subscribe for More Information
11:25 EDTBIIBPTAB declares interference between Forward Pharma and Biogen regarding treatment
Subscribe for More Information
07:10 EDTACNAviation Week to hold a conference
MRO Americas 2015 is being held in Miami Beach on April 14-16.
06:10 EDTACNStocks with implied volatility below IV index mean; LL ACN
Subscribe for More Information
April 13, 2015
15:16 EDTGMEGameStop management to meet with Piper Jaffray
Subscribe for More Information
10:58 EDTHUMCigna, Humana seen as potential takeover targets in Managed Care space
Subscribe for More Information
08:05 EDTPLCEChildren's Place rejects director nominations from Barington, Macellum
The Children's Place confirmed that it has received notice from Barington Capital Group, L.P. and Macellum Advisors GP, LLC, which collectively own less than 2% of the company’s shares, that they have nominated three individuals in opposition to The Children’s Place’s three nominees -- Norman Matthews, Kenneth Reiss and Stanley Reynolds -- standing for re-election to the Board of Directors at the company’s 2015 Annual Meeting of Stockholders, to be held on May 22, 2015. The Children’s Place's Board of Directors has evaluated Barington and Macellum’s nominees and concluded that the company’s three nominees and the other members of the Board have the right combination of expertise, experience and independence. As such, the Board recommends election of the company’s nominees and has rejected the Barington/Macellum nominees. Stockholders do not need to take any action at this time. Matthews continued: “We appreciate constructive input from our shareholders and are always open to listen to ideas to improve the Company. However, we believe that Barington and Macellum’s views on the Company’s leadership and performance are simply incorrect. Our Board and management team are driving a transformation of The Children’s Place, which has resulted in a significant increase in shareholder value, measured by an increase in stock price, share repurchases and the payment of dividends. Substantial progress has been made, and we expect to continue to see the benefits of our meaningful investments in 2015. Our management team has updated our merchandise assortments, developed and is implementing a sweeping systems and technology transformation plan, transformed our outlet channel, launched international franchise and wholesale businesses, and evaluated and continues to optimize our store fleet. We believe The Children’s Place is well positioned to continue to excel in the intensely competitive specialty children’s apparel category.” Goldman, Sachs & Co. is financial advisor to The Children’s Place. Paul, Weiss, Rifkind, Wharton & Garrison LLP is the Company’s legal advisor.
07:33 EDTHUMJefferies sees low probability of WellCare, Centene buyouts
After running several acquisition scenarios for the Managed Care space, Jefferies says potential takeovers of WellCare (WCG) and Centene (CNC) are "hard to justify." The firm estimates acquirers will only be able to generate 1%-3% accretion from buying either company at a 20% premium to current share prices. The deal that makes the most financial sense is Aetna (AET) buying Cigna (CI), Jefferies says today in a note to investors. Also financially attractive would be a buyout of Humana (HUM) by either Anthem (ANTM) or Aetna, the firm adds. After analyzing the Managed Care space, it upgraded this morning shares of UnitedHealth (UNH) to Buy from Hold with a $141 price target. Jefferies also has Buy ratings on Aetna, Anthem, Health Net (HNT) and Molina Healthcare (MOH).
05:29 EDTACNAccenture awarded three-year contract by UniCredit
Subscribe for More Information
April 12, 2015
15:42 EDTACNAccenture shares may rise 26% over next three years, Barron's says
Accenture stock is not currently undervalued but could rise 26% to $120 in the next three years, Barron's contends in its "Follow Up" column. Analysts expect strong earnings and recommend holding the stock or buying shares if prices were to fall, the paper adds. Reference Link
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use